Chongqing Lummy Pharmaceutical Co., Ltd.

¥9.76As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300006Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 1.50%
Div yield —
ROE (6.34%)
Drug Manufacturers (General)
Beta (5Y) 0.02
PE TTM —
TSR TTM 110.80%
Mkt cap ¥10.31B
ROIC (5.32%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥12
21.40%
121.54%
Sell 4|4|1|3|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.10
0.10
0.11
0.12
10.44%
12.09%
19.11%
31.46%
Revenue¥M
826.3
814.0
861.9
910.1
15.85%
9.77%
12.31%
12.75%
Peers (US$1.545B)
Cap (US$)
PE
1.479B
—
Capital
TTM
5Y
10Y
Leveragex
1.557
(0.045)
(0.048)
EBIT/Intx
0.149
0.201
0.185
Own earn%
107.33
(3.46)
(4.94)
Sh yield%
28.04
48.86
51.66
Owners
Insiders/Inst%
5.05
69.34
Short interest%
1.62
SBC / revenue%
1.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
0–5
$1 testx
0.0
Incr. ROIC%
7